Regulation of Anti-Phosphatidylserine Antibodies

Slides:



Advertisements
Similar presentations
Tumor spectrum analysis in p53-mutant mice
Advertisements

Volume 15, Issue 2, Pages (August 2001)
Volume 93, Issue 3, Pages (May 1998)
Role of AP1/NFE2 binding sites in endogenous α-globin gene transcription by Melanie R. Loyd, Yasuhiro Okamoto, Mindy S. Randall, and Paul A. Ney Blood.
Nienke van der Stoep, James R Gorman, Frederick W Alt  Immunity 
Contribution of VH Gene Replacement to the Primary B Cell Repertoire
Mutation Spectrum of the Survival of Motor Neuron 1 and Functional Analysis of Variants in Chinese Spinal Muscular Atrophy  Yu-jin Qu, Jin-li Bai, Yan-yan.
Isothermal Multiple Displacement Amplification
Volume 5, Issue 3, Pages (September 1996)
Volume 7, Issue 4, Pages (October 1997)
Volume 25, Issue 1, Pages (July 2006)
Volume 18, Issue 6, Pages (June 2003)
Volume 7, Issue 6, Pages (December 1997)
Brca1 Controls Homology-Directed DNA Repair
Volume 15, Issue 1, Pages (July 2001)
Volume 2, Issue 4, Pages (October 1998)
Volume 5, Issue 2, Pages (February 2000)
Volume 19, Issue 6, Pages (December 2003)
Redundant and Unique Roles of Two Enhancer Elements in the TCRγ Locus in Gene Regulation and γδ T Cell Development  Na Xiong, Chulho Kang, David H Raulet 
Thorsten Buch, Frédéric Rieux-Laucat, Irmgard Förster, Klaus Rajewsky 
Volume 5, Issue 4, Pages (October 1996)
Volume 11, Issue 4, Pages (October 1999)
Volume 16, Issue 6, Pages (June 2002)
Volume 28, Issue 2, Pages (February 2008)
The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal
Volume 9, Issue 4, Pages (October 1998)
Volume 10, Issue 5, Pages (May 1999)
Balthazar B Cazac, Jürgen Roes  Immunity 
Volume 154, Issue 6, Pages (September 2013)
Impaired Development of Th2 Cells in IL-13-Deficient Mice
In Vivo Ablation of Surface Immunoglobulin on Mature B Cells by Inducible Gene Targeting Results in Rapid Cell Death  Kong-Peng Lam, Ralf Kühn, Klaus.
Volume 18, Issue 2, Pages (February 2003)
Volume 9, Issue 6, Pages (December 1998)
CD22 is a negative regulator of B-cell receptor signalling
Andrew J Henderson, Ruth I Connor, Kathryn L Calame  Immunity 
Direct Interactions of OCA-B and TFII-I Regulate Immunoglobulin Heavy-Chain Gene Transcription by Facilitating Enhancer-Promoter Communication  Xiaodi.
Yang Xu, Genhong Cheng, David Baltimore  Immunity 
A Point Mutation in the Constant Region of Ig Lambda1 Prevents Normal B Cell Development due to Defective BCR Signaling  Tianhe Sun, Marcus R Clark, Ursula.
Volume 24, Issue 4, Pages (April 2006)
Volume 5, Issue 3, Pages (September 1996)
Volume 87, Issue 5, Pages (November 1996)
Both E12 and E47 Allow Commitment to the B Cell Lineage
Volume 4, Issue 4, Pages (April 1996)
The Basis for IL-2-Induced IL-2 Receptor α Chain Gene Regulation
Volume 16, Issue 5, Pages (May 2002)
Ludovica Bruno, Hans Jörg Fehling, Harald von Boehmer  Immunity 
Increased Junctional Diversity in Fetal B Cells Results in a Loss of Protective Anti- Phosphorylcholine Antibodies in Adult Mice  Cindy L Benedict, John.
A Prematurely Expressed Igκ Transgene, but Not a VκJκ Gene Segment Targeted into the Igκ Locus, Can Rescue B Cell Development in λ5-Deficient Mice  Roberta.
IgH Class Switch Recombination to IgG1 in DNA-PKcs-Deficient B Cells
Impaired Development of Th2 Cells in IL-13-Deficient Mice
Volume 34, Issue 1, Pages (April 2009)
Volume 84, Issue 4, Pages (February 1996)
The Shaping of the T Cell Repertoire
Targeted Mutagenesis of the Endogenous Mouse Mis Gene Promoter
Volume 21, Issue 6, Pages (December 2004)
Multiple Developmental Stage–Specific Enhancers Regulate CD8 Expression in Developing Thymocytes and in Thymus-Independent T Cells  Wilfried Ellmeier,
Volume 8, Issue 1, Pages (January 1998)
Joan E Durbin, Renée Hackenmiller, M.Celeste Simon, David E Levy  Cell 
Volume 10, Issue 4, Pages (April 1999)
Rodney P. DeKoter, Hyun-Jun Lee, Harinder Singh  Immunity 
Volume 21, Issue 6, Pages (December 2004)
Volume 9, Issue 3, Pages (September 1998)
Volume 9, Issue 2, Pages (February 2002)
The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal
Volume 94, Issue 2, Pages (July 1998)
B Cell Development under the Condition of Allelic Inclusion
Volume 4, Issue 2, Pages (February 1996)
Mutation of the Ca2+ Channel β Subunit Gene Cchb4 Is Associated with Ataxia and Seizures in the Lethargic (lh) Mouse  Daniel L Burgess, Julie M Jones,
Bcl-2 Obstructs Negative Selection of Autoreactive, Hypermutated Antibody V Regions during Memory B Cell Development  Shailaja Hande, Evangelia Notidis,
Volume 4, Issue 5, Pages (May 1996)
Presentation transcript:

Regulation of Anti-Phosphatidylserine Antibodies Hui Li, Yufei Jiang, Hong Cao, Marko Radic, Eline Luning Prak, Martin Weigert  Immunity  Volume 18, Issue 2, Pages 185-192 (February 2003) DOI: 10.1016/S1074-7613(03)00026-8

Figure 1 Somatic Replacement Mutations and Their Specificities (A) The 3H9 clone produces an Ab with higher affinity for both ssDNA and dsDNA than its siblings. We attribute this to the glycine to arginine mutation in CDR2. The 3H9H gene rearrangement is the substrate for in vitro mutagenesis. We have derived higher affinity mutants by sequential mutations to arginine of the aspartate at position 56 and the serine at position 76 of the 3H9 H chain. Here, we explore the effect of reverting the 3H9H to its germline sequence 3H9H/GL. The solid lines represent the mutations that occurred naturally. The dashed lines represent the mutations that were created in vitro. (B) Antigen specificity and relative binding of 3H9 variants. The data are taken from references (Radic et al., 1993a; Cocca et al., 2001) and normalized to 3H9. The data were derived using bivalent molecules. The DNA binding assays used IgG2b H chains paired with the λ1 L chain, whereas phospholipid binding was assayed by using homodimers of scFv containing the indicated VH and the 3H9 VL. Dashes indicate that readings remained below half maximal OD. Immunity 2003 18, 185-192DOI: (10.1016/S1074-7613(03)00026-8)

Figure 2 Site-Directed Replacement of the JH Locus with the 3H9/GL VH Gene Arrows indicate the transcriptional orientations of the neomycin, VDJ, and HSV-TK genes. Homologous flanking sequences facilitate recombination between the targeting vector (A) and the germline IgH locus (B). The regions of homology are stippled. A 7.9 kb EcoRI restriction fragment is obtained with the replaced IgH locus (C and F) while a 6.4 kb fragment was derived from the germline locus (B and F). The position of the JH probe (pJ11) and the PCR primers is shown (D). PCR analysis of targeted ES cells is shown in (E). Vector DNA with the binding sites for both DH1.5 and neo primers (expected size of the PCR product is 0.9 kb) is used as a positive control. DNA from 3H9H/GL-targeted ES cells was assayed for homologous recombination by DH1.5/neo PCR. The expected size of the DH1.5/neo PCR product in targeted ES cells is 1.5 kb. The pGEM DNA marker (Promega) is loaded in the first lane. Southern blot analysis was performed using EcoR1 digested genomic DNA from transfected ES clones that tested positive by DH1.5/neo PCR. The DNA was hybridized with pJ11. The observed bands at (F) indicate proper targeting, 6.4 kb (germline) and 7.9 kb (targeted) (B and C). PCR analysis of ES cell-derived offspring is shown in (G). Tail DNA of a heterozygous mouse (3H9H/GL/+) and a wild-type littermate (+/+) were tested for the presence of the 3H9H/GL sd-tg by LD/CDR3 PCR (expected size is 0.45 kb). Water was used as a negative control in PCR. Immunity 2003 18, 185-192DOI: (10.1016/S1074-7613(03)00026-8)

Figure 3 H Chain Allelic Exclusion in 3H9H/GL sd-tg Mice The 3H9H/GL sd-tg mice on BALB/c background were crossed to CB17 to verify expression of the sd-tg. The targeted allele is of the μa allotype, being derived from 129/Ola ES cells, while the CB17 locus is of the μb allotype. FACS profiles of splenocytes from 3H9H/GL/BALB/c x CB17 (F1) and a transgene-negative littermate control show staining of IgMa and IgMb populations. Cells were gated on the B220+ population. Immunity 2003 18, 185-192DOI: (10.1016/S1074-7613(03)00026-8)

Figure 4 Phosphatidylserine (PS) Binding of Hybridoma Supernatants PS binding of supernatants of 3H9H/GL, 3H9H, and 3H9H/56R hybrids was performed as described in the Experimental Procedures. All of these hybrids have retained the sd-tg H chain except the 3H9− group in the 3H9H fusion. The results are displayed as groups according to the usage of editor L chains in each fusion. Vκ+ group includes the hybrids with the rearrangements that were detected by either Vκs or L5 primers. They are further divided into subgroups according the Jκ usage of Vκ12+ hybrids in the 3H9H fusion. PS binding was displayed as OD405 and normalized to an Ig concentration of 1 μg/ml. The fluctuation in the assay was determined by measuring the same samples five times. The range of fluctuation was 0.6 OD units. Therefore, the fluctuation seen in measurements of the same antibody is partially due to the experimental error. Each data point represents an individual mAb. Only the supernatants from the second 3H9H/GL fusion were used for PS binding. *One Vκ38c clone was found in the second 3H9H/GL fusion while none in the first fusion (Table 1). Supernatants of 3H9H/56R hybrids were from a fusion using 3H9H/56R-κdel/κ+ sd-tg mice (our unpublished data). Immunity 2003 18, 185-192DOI: (10.1016/S1074-7613(03)00026-8)

Figure 5 Influence of Aspartates of the Vκ Editors on the Electrostatic Potentials of Variable Regions of 3H9H/GL and 3H9H A template (PDB code 1I8M) was chosen from the Protein Data Bank (http://www.rcsb.org/pdb) based on its sequence similarity to Vκ12. Predicted models of 3H9/GL-Vκ12 ([A], left), 3H9-Vκ12 ([A], right), 3H9-Vκ20 ([B], left), 3H9/56R-Vκ20 ([B], middle), 3H9/56R-Vκ21-4 ([B], right), 3H9/56R-Vκ20 ([C], left), and 3H9/56R-Vκ21-4 ([C], right) were reconstructed by Swiss Model (http://www.expasy.org/swissmod/sm_webmodel.html). (A) and (B) represent the top looking down into the combining sites. (C) provides the side views of the combining sites. The electrostatic potentials of each model were calculated with GRASP and are represented on a color scale from blue for positive potential, to white for neutral, to red for negative potential. Immunity 2003 18, 185-192DOI: (10.1016/S1074-7613(03)00026-8)